1. Tebentafusp (Kimmtrak): CADTH Reimbursement Review [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Apr. 
Report No.: PC0290CL.
CADTH Reimbursement Reviews and Recommendations.

PMID: 37903202
